Page last updated: 2024-12-10

gentamicin c

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gentamicin C: RN given refers to cpd with unknown MF; see also record for micronomicin for which gentamicin C2b is synonym [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3084091
MeSH IDM0262584

Synonyms (3)

Synonym
11097-82-8
gentamicin c
(2r,3s,4r,5r)-2-[(1s,2r,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The adverse effect to the inner ear of aminoglycosides, drugs widely administered for the treatment of serious infections, appears to result from the interaction of these drugs with Cu(II) or Fe(II)/Fe(III) ions."( Solution chemistry of copper(II)-gentamicin complexes: relevance to metal-related aminoglycoside toxicity.
Harris, WR; Kravitz, JY; Lesniak, W; Pecoraro, VL; Schacht, J, 2003
)
0.6

Pharmacokinetics

ExcerptReferenceRelevance
" The pharmacokinetic analysis of the plasma concentration-versus-time data was performed using the noncompartmental approach."( Pharmacokinetics of gentamicin C(1), C(1a), and C(2) in beagles after a single intravenous dose.
Isoherranen, N; Lavy, E; Soback, S, 2000
)
0.63
" Significant differences in clearance, half-life (t 1/2), and mean residence time (MRT) between the gentamicin Cia and the 2 other components were found."( Pharmacokinetics of gentamicin C1, C1a and C2 in horses after single intravenous dose.
Ashoach, O; Isoherranen, N; Soback, S; Steinman, A, 2002
)
0.85
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (20.00)18.7374
1990's1 (2.86)18.2507
2000's14 (40.00)29.6817
2010's9 (25.71)24.3611
2020's4 (11.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.41 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.76 (4.65)
Search Engine Demand Index25.55 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.78%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (97.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]